NATCO Pharma Limited (NATCOPHARM.NS)

INR 1473.0

(1.89%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 69.06 Billion 56.57 Billion 51.09 Billion 47.91 Billion 45.87 Billion 43.03 Billion
Total Current Assets 40.23 Billion 30 Billion 24.97 Billion 23.37 Billion 23.25 Billion 23.47 Billion
Cash And Short Term Investments 13.96 Billion 11.62 Billion 7.59 Billion 8.1 Billion 9.02 Billion 10.57 Billion
Cash and Cash Equivalents 9.52 Billion 1.31 Billion 1.11 Billion 258 Million 198 Million 283 Million
Short Term Investments 4.43 Billion 10.3 Billion 6.48 Billion 7.84 Billion 8.82 Billion 10.29 Billion
Net Receivables 11.97 Billion 8.66 Billion 6.71 Billion 4.7 Billion 6.33 Billion 6.85 Billion
Inventory 7 Billion 7.42 Billion 7.62 Billion 7.98 Billion 5.58 Billion 5.29 Billion
Other Current Assets 7.28 Billion 2.29 Billion 3.04 Billion 2.58 Billion 8.65 Billion 750 Million
Total Non-Current Assets 28.82 Billion 26.57 Billion 26.11 Billion 24.54 Billion 22.62 Billion 19.55 Billion
Net PPE 24.35 Billion 23.03 Billion 23.08 Billion 22.37 Billion 20.93 Billion 18.56 Billion
Good Will And Intangible Assets 1.93 Billion 1.87 Billion 1.32 Billion 94 Million 88 Million 87 Million
Good Will 560 Million 552 Million 507 Million - - -
Intangible Assets 1.37 Billion 1.32 Billion 822 Million 94 Million 88 Million 87 Million
Long-Term Investments 1.39 Billion -9.25 Billion -5.65 Billion -6.25 Billion -7.99 Billion -10.09 Billion
Tax Assets 194 Million 10.64 Billion 6.88 Billion 8.04 Billion 9.58 Billion 10.98 Billion
Other Non Current Assets 955 Million 271 Million 469 Million 285 Million -1 Million 17 Million
Other Assets - - - - - -
Total Liabilities 10.53 Billion -34.8 Billion 8.45 Billion 6.68 Billion 8.03 Billion 8.12 Billion
Total Current Liabilities 9.72 Billion 6.83 Billion 7.1 Billion 5.25 Billion 6.85 Billion 7.28 Billion
Account Payables 2.35 Billion 2.63 Billion 1.61 Billion 1.46 Billion 2.55 Billion 2.17 Billion
Tax Payables 323 Million 101 Million 9 Million 13 Million 85 Million 66 Million
Short Term Debt 3.65 Billion 1.65 Billion 4.24 Billion 2.83 Billion 3.28 Billion 3.86 Billion
Deferred Revenue 323 Million 1.12 Billion 877 Million 13 Million 85 Million 66 Million
Other Current Liabilities 3.39 Billion 1.4 Billion 369 Million 951 Million 929 Million 1.18 Billion
Total Non Current Liabilities 804 Million -41.63 Billion 1.35 Billion 1.42 Billion 1.17 Billion 834 Million
Long-Term Debt 53 Million 11 Million 80 Million 9 Million 9 Million -
Deferred Revenue Non Current - 870 Million 13 Million 11 Million 8 Million 8 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 749 Million -42.63 Billion 957 Million 996 Million 902 Million 710 Million
Other Liabilities - - - - - -
Total Equity 58.53 Billion 91.37 Billion 42.63 Billion 41.23 Billion 37.84 Billion 34.91 Billion
Stock Holders Equity 58.53 Billion 48.73 Billion 42.63 Billion 41.21 Billion 37.73 Billion 34.89 Billion
Common Stock 358 Million 365 Million 365 Million 365 Million 364 Million 365 Million
Retained Earnings 44.65 Billion 32.92 Billion 26.66 Billion 25.68 Billion 22.39 Billion 19.57 Billion
Accumulated other comprehensive income 58.17 Billion 1.38 Billion 1.52 Billion 1.25 Billion -5.5 Billion -4.57 Billion
Common Stock Equity 58.53 Billion 48.73 Billion 42.63 Billion 41.21 Billion 37.73 Billion 34.89 Billion
Capital Lease Obligation 53 Million 17 Million 115 Million 18 Million 17 Million -
Total Investments 5.83 Billion 1.04 Billion 1.04 Billion 1.59 Billion 836 Million 199 Million
Total Debt 3.71 Billion 1.66 Billion 4.32 Billion 2.83 Billion 3.29 Billion 3.86 Billion
Net Debt -5.81 Billion 348 Million 3.2 Billion 2.58 Billion 3.09 Billion 3.58 Billion

Balance Sheet Charts